Alzheimer Disease Clinical Trials in Stanford, California
2 recruitingStanford, California
Showing 1–2 of 2 trials
Recruiting
Phase 2
Bumetanide in Patients With Alzheimer's Disease
Alzheimer Disease
Stanford University40 enrolled1 locationNCT06052163
Recruiting
Phase 1Phase 2
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Amyotrophic Lateral Sclerosis(ALS)Alzheimer Disease (AD)Parkinson Disease (PD)+1 more
Ashvattha Therapeutics, Inc.65 enrolled3 locationsNCT05395624